Stomach cancer (Gastric cancer, GC) is a serious malignant disorder. Understanding the mechanism of stomach cancer development, and the discovery of novel diagnostic biomarkers and therapeutics are major goals in stomach cancer research. Important pathways, like, ECM-receptor interaction, Gastric acid secretion, PI3K-Akt signaling pathway, Focal adhesion, Amoebiasis, and Collecting duct acid secretion, linked with stomach cancer are identified. The genes associated with these pathways, i.g., COL1A1, COL1A2, THBS2, FN1, SPP1, ATP4A, APOE, VCAN, TIMP1, and ATP4B, are considered as the potential targets for stomach cancer drug discovery.
We have applied omics technologies in stomach cancer research, with a special focus on the utilization of computational approaches to integrate multi-omics data. The application of data-driven systems biology and machine learning approaches could provide a predictive understanding of stomach cancer, and pave the way for the development of novel biomarkers and rational design of cancer therapeutics.
CD ComputaBio has multiple resources including academic research and preclinical works in the identification of a suitable disease target and its corresponding hit. Contact us for more service details.
References
Submit your project details below, and our team will respond within 24 hours.
Talk to our technical team about your project!
I Want To Talk